Andrew S Bell

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 3

Top Topics

Molecular Dynamics Simulations

Plasmodium Falciparum

Top Venues

Nature chemistry

PLoS neglected tropical diseases

Journal of medicinal chemistry

Myricx Pharma

Imperial College London (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Myricx Pharma Jun 24 2019

United Kingdom

Consultant

Salvensis Jun 23 2014

United Kingdom

Consultant

exscientia Apr 01 2014

United Kingdom

Chief Research Officer

Pfizer Global Research and Development Europe Jun 01 1980 - Aug 31 2011

United Kingdom

Research Fellow :: Worldwide Medicinal Chemistry

Education History

Imperial College London Oct 01 2011 - Dec 31 2017

United Kingdom

PHD :: Chemistry

Publications

J Mark F Gardner, Nuha R Mansour, Andrew S Bell, Helena Helmby, Quentin Bickle
The discovery of a novel series of compounds with single-dose efficacy against juvenile and adult Schistosoma species. PLoS neglected tropical diseases 15 (7) (2021)
Andrew S Bell, Zhiyong Yu, Jennie A Hutton, Megan H Wright, James A Brannigan, Daniel Paape, Shirley M Roberts, Charlotte L Sutherell, Markus Ritzefeld, Anthony J Wilkinson, Deborah F Smith, Robin J Leatherbarrow, Edward William Tate
Novel Thienopyrimidine Inhibitors of Leishmania N-Myristoyltransferase with On-Target Activity in Intracellular Amastigotes. Journal of medicinal chemistry 63 (14) (2020)
Aurélie Mousnier, Andrew S Bell, Dawid P Swieboda, Julia Morales-Sanfrutos, Inmaculada Pérez-Dorado, James A Brannigan, Joseph Newman, Markus Ritzefeld, Jennie A Hutton, Anabel Guedán, Amin S Asfor, Sean W Robinson, Iva Hopkins-Navratilova, Anthony J Wilkinson, Sebastian L Johnston, Robin J Leatherbarrow, Tobias J Tuthill, Roberto Solari, Edward William Tate
Fragment-derived inhibitors of human N-myristoyltransferase block capsid assembly and replication of the common cold virus. Nature chemistry 10 (6) (2018)